Keywords: eli, lilly, vertex, restructure, hep, deal, longer

Eli Lilly, Vertex restructure hep C deal

Article | 06 January 2003

Print This

Eli Lilly will no longer participate with Vertex Pharmaceuticals onthe development of a hepatitis C virus drug, VX-950, and will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in